Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ARGX
ARGX News & Events
-
Add to Watchlist
Trade ARGX Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ARGX News
argenx Hosts Webinar on Advancing FcRn Leadership in Autoimmune Myositis
Jun 23 2026
Newsfilter
argenx Hosts Webinar on Advancing FcRn Leadership in Autoimmune Myositis
Jun 23 2026
Yahoo Finance
Argenx Releases New Clinical Data for Efgartigimod in Myositis and Sjogren's Disease
Jun 03 2026
NASDAQ.COM
argenx Presents New Efgartigimod Data at EULAR 2026
Jun 03 2026
Newsfilter
argenx Hosts Webinar on Advancing FcRn Leadership in Autoimmune Myositis
May 28 2026
Newsfilter
argenx Management to Attend Investor Conferences in June
May 27 2026
Newsfilter
MindWalk Reports Significant Progress in Drug Development
May 18 2026
Newsfilter
argenx SE Receives FDA Approval for VYVGART Label Expansion
May 11 2026
NASDAQ.COM
Show More News
ARGX Events
No data
ARGX Monitor News
argenx SE reaches 52-week high amid sector rotation
Jul 02 2026
argenx to Host Webinar on FcRn Leadership in Autoimmune Myositis
Jun 25 2026
argenx to Host Webinar on FcRn Leadership in Autoimmune Myositis
Jun 23 2026
argenx SE reaches 20-day high amid sector rotation
Jun 22 2026
argenx reports positive efgartigimod data for autoimmune diseases
Jun 05 2026
argenx Reports Positive Efgartigimod Data for Autoimmune Diseases
Jun 04 2026
argenx Receives FDA Approval for VYVGART Label Expansion
May 11 2026
argenx SE hits 20-day low amid market decline
Mar 18 2026
Show More Monitor News
ARGX Earnings Analysis
Argenx SE Earnings: Immunology Innovations Drive Growth- Intellectia AI™
8 months ago
argenx SE 2024: Earnings Growth & Strategic Advancements- Intellectia AI™
1 years ago
People Also Watch
